Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2005
03/10/2005WO2004075723A3 Methods for the early diagnosis of ovarian cancer
03/10/2005WO2004056971A3 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
03/10/2005WO2004050674A3 Methods and materials for modulating trpm2
03/10/2005WO2004048411A3 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion
03/10/2005WO2004017902A3 Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system
03/10/2005WO2003104260A3 Pharmaceutical formulation
03/10/2005WO2003103475A3 Prevention and reduction of blood loss
03/10/2005WO2003092720A8 A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
03/10/2005WO2003060075A3 USE OF SOLUBLE TYPE II TGF-β RECEPTOR TO SUPPRESS PANCREATIC CANCER GROWTH AND METASTASIS
03/10/2005WO2003052062A3 Antisense modulation of cd36l1 expression
03/10/2005WO2003037167A9 Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor
03/10/2005WO2003027254A9 15625 receptor, a novel g-protein coupled receptor
03/10/2005WO2002087604A8 Preparations containing a combination of vitamin e and afamin
03/10/2005WO2001066772A9 Heparinase iii and uses thereof
03/10/2005WO2001011335A3 Antiviral compounds that inhibit viral replication
03/10/2005US20050055735 Use of complement protein C3 and its derivatives in enhancing mammalian embryo development
03/10/2005US20050055010 Method for altering insulin pharmacokinetics
03/10/2005US20050054845 Thymosin augmentation of genetic immunization
03/10/2005US20050054843 Subtilisin comprising b-cell epitope for use in detergents, textile treatment, liquid soaps, cosmetics and contact lense cleaning solutions
03/10/2005US20050054837 Activity dependent neurotrophic factor I complex (ADNF I complex) for use as tool in reducing conditions associated with fetal alcohol syndrome and enhancing learning and memory
03/10/2005US20050054836 Chimeric molecules to modulate gene expression
03/10/2005US20050054835 Immunoglobulin fusion comprising gelonin and shiga-like toxin for use in treatment and prevention of graft vs host, autoimmue and cell proliferative disorders
03/10/2005US20050054833 Immunoglobulin fusion for use in treatment and prevention of asthma, food allergies, sinus inflammation and vision defects
03/10/2005US20050054827 Conotoxin amino acid sequences for use as tool in controlling pain; immunotherapy; mimetics
03/10/2005US20050054825 Osteogenic devices
03/10/2005US20050054820 Expression vector comprising nucleotide sequences coding calreticulin/heat shock protein fusion for use as tool in enhancement and induction of major histocompatibility complex immunological response; immunotherapy; tissue targeted therapy
03/10/2005US20050054818 Preparing non-adsorbed insulin crystals using mixture comprising polypeptide, zinc, protamine and a hexamer-stabilizing compound; therapeutic compound for use in prevention and treatment of diabetes and hyperglycemia; antidiabetic agents
03/10/2005US20050054719 Dimeric compounds and their use as anti-viral agents
03/10/2005US20050054665 Adjust gene expresion; induction of immunology response; leukemia; antcancer agents; vaccines
03/10/2005US20050054663 GSK-3 inhibitors
03/10/2005US20050054617 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
03/10/2005US20050054608 Using insulin or peroxisome proliferator activator; applying to injuries
03/10/2005US20050054603 gene expression inhibition; hairpin nucleic acids; for treatment of viral infections, tumors, and cancer
03/10/2005US20050054600 Modified protein kinase a-specific oligonucleotides and methods of their use
03/10/2005US20050054598 RNA interference mediated inhibition hairless (HR) gene expression using short interfering nucleic acid (siNA)
03/10/2005US20050054596 useful in modulating vascular endothelial growth factor (VEGF) and/or vascular endothelial growth factor receptor (e.g., VEGFR) gene expression; used in therapeutic, diagnostic, target validation, and genomic discovery
03/10/2005US20050054593 New drug
03/10/2005US20050054591 Yin yang-1
03/10/2005US20050054581 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
03/10/2005US20050054580 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
03/10/2005US20050054579 New crystalline forms
03/10/2005US20050054578 Topical cosmetic which increases elasticity of skin; low molecular weight peptide
03/10/2005US20050054576 Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
03/10/2005US20050054575 Peptide agonists of prostate-specific antigen and uses therefor
03/10/2005US20050054574 Using calcium channel blockers
03/10/2005US20050054573 Kit for detection, monitoring kinase, phosphatase; mixture of peptides; detectable compound; adjustment proteolytic sensitivity
03/10/2005US20050054572 Methods for obtaining molecules with reduced immunogenicity
03/10/2005US20050054571 Antimicrobial proteins from the SPO1 bacteriophage
03/10/2005US20050054569 Mutants and assay system to identify USP/RXR ligands
03/10/2005US20050054568 Angiogenesis-modulating compositions and uses
03/10/2005US20050054567 Polypeptides; adjust concentration of stem cells
03/10/2005US20050054565 Agonists and antagonists of moxifin for the treatment of metabolic disorders
03/10/2005US20050054564 Proteins for use in treatment of gastrointestinal disorders; novel gene product designated Antrum Mucosal Protein 18 ("AMP-18") is a gastrokine
03/10/2005US20050054563 Transgenic bacteria host cell can be used for screening antibiotics , herbicides; genetic engineering; therapy for bone disorders; antiarthritic agents
03/10/2005US20050054562 Gastrointestinal disorders; antiulcer agents; pancreatitis; antidiabetic agents
03/10/2005US20050054561 Abuse-resistant amphetamine compounds
03/10/2005US20050054560 Cd44 variants carrying heparan sulfate chains and uses thereof
03/10/2005US20050054559 Compounds for sustained release of orally delivered drugs
03/10/2005US20050054558 Administering macrophage derived factor; oncomodulin; nerve growth factors; kits
03/10/2005US20050054557 Osteoporosis therapy; concurrent administering by mouth
03/10/2005US20050054556 Therapy for rheumatic disease; mixture of antiinflammatory agent and albumin hydrolyzates
03/10/2005US20050054555 Kahalalide compounds for use in cancer therapy
03/10/2005US20050054108 Yeast membrane protein expression system and its application in drug screening
03/10/2005US20050054094 SPRR1A and axonal regeneration
03/10/2005US20050054090 MHC class II antigen-presenting systems and methods for activating CD4cells
03/10/2005US20050054072 Proteases and variants thereof
03/10/2005US20050054070 Mammalian protein phosphatases
03/10/2005US20050054055 Using transgenic rodents as bioreactor for generation of immunoglobulins for use as tools in immunotherapeutics and diagnostics
03/10/2005US20050054053 Interferon variants with improved properties
03/10/2005US20050054052 Therapeutic cytokine for use in prevention and treatment of viral diseases
03/10/2005US20050054051 Albumin fusion proteins
03/10/2005US20050054043 Metal binding human transferrins for use as tool in removing toxic metals from patients in metal chelation therapy; tissue culture medium supplements
03/10/2005US20050054036 Growth factor isoform
03/10/2005US20050054033 Methods and compositions for treating and preventing infection using human interferon regulatory factor 3
03/10/2005US20050053995 Staphylococcus aureus genes and polypeptides
03/10/2005US20050053994 Expression vector comprising nucleotide sequences coding phosphodiesterase for use in the treatment and prevention of autoimmune, respiratory system and pulmonary disorders; gene therapy; tissue engineering
03/10/2005US20050053988 Gene expressed in breast cancer and methods of use
03/10/2005US20050053987 Oxidoreductase molecules
03/10/2005US20050053953 Novel human genes and proteins encoded thereby
03/10/2005US20050053943 Transmembrane protein for use in the diagnosis, detection, prevention and treatment of cell proliferative disorders; immunotherapy
03/10/2005US20050053935 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
03/10/2005US20050053931 Method for the diagnosis and therapy of renal cell carcinoma
03/10/2005US20050053930 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/10/2005US20050053919 Using negative-sense single stranded RNA viral sequences as diagnostic tool in detection of respiratory syncytial viral infection
03/10/2005US20050053917 Core structure of gp41 from the HIV envelope glycoprotein
03/10/2005US20050053914 Nucleotide sequences coding hepatitis envelope protein for use as tool in detecting hepactocyte receptors; drug screening, viricides and treatment of viral diseases
03/10/2005US20050053705 Soluble soy protein with superior functional properties
03/10/2005US20050053675 Method of making, and the use of cytotoxic agents containing elemental selenium
03/10/2005US20050053664 Reduced toxicity; enhance efficiency; side effect reduction; anticarcinogenic agent; administering to a cancer patient admixture having (((1,4)-linked beta -D-mannopyranose)17-((1,6)-linked- beta -D-galactopyranose)10)12) and a chemotherapeutic agent
03/10/2005US20050053625 Method of treating viral infections
03/10/2005US20050053614 Prevention and treatment of amyloidogenic disease
03/10/2005US20050053607 Proteins for treatment of cancer by administering antinucleolin
03/10/2005US20050053606 MUC1 extracellular domain and cancer treatment compositions and methods derived therefrom
03/10/2005US20050053604 Administering avian polyclonal antibodies to treat inflammatory bowel disease in birds or humans and for colitis including Crohn's disease
03/10/2005US20050053603 Monocyte chemoattractant protein for treatment of liver diseases and antibodies thereof
03/10/2005US20050053601 Protein with amino acid sequences for central nervous systems in mammals
03/10/2005US20050053599 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
03/10/2005US20050053597 Composition and method for treatment of wounds
03/10/2005US20050053596 Extracellular material used in formation of new bones and bone growth for repair or regeneration
03/10/2005US20050053595 White cream bacteriostats, fungicide as vehicle for drug; receptivity
1 ... 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 ... 3163